Wacker and Gearbox Biosciences agreed to collaborate to advance plasmid DNA manufacturing technologies. By combining Wacker’s expertise in GMP manufacturing of biologics, including pDNA, with Gearbox ...
The first peer-reviewed journal in the field of human gene therapy, providing all-inclusive coverage of the research, methods, and clinical developments that are driving today's explosion of gene ...
School of Natural Sciences, University of Kent, Canterbury, United Kingdom Delivery of DNA into nucleated eukaryotic cells is known as transfection and has been essential in establishing technologies ...
- EffiX™ is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. It serves as a comprehensive solution for the development and manufacturing of ...
Credit: ImmunityBio. Developed by the Serum Institute of India, the rBCG product, which has been modified to improve its immunogenicity and safety, was evaluated in phase 1/2 clinical trials in Europe ...
1 Department of Agricultural Biotechnology, National Institute of Agricultural Sciences, Rural Development Administration, Jeonju, Republic of Korea 2 Department of Plant Medicals, Andong National ...
According to the report, the U.S. viral vector and plasmid DNA manufacturing market size was estimated at USD 2.45 billion in 2023 and is projected to hit around USD 15.30 billion by 2033, growing at ...
According to recent study by Nova one advisor, the U.S. plasmid DNA manufacturing market size was USD 711.90 million in 2023, calculated at USD 863.11 million in 2024 and is expected to reach around ...
As Japanese chemical giant Asahi Kasei continues its foray into the biopharma contract manufacturing space, the company’s biologics CDMO is expanding its offerings to include starting materials for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results